TTK Healthcare Limited (TTKHLTCARE.NS)
INR 1144.0
(-0.83%)
INR 1144.0
(-0.83%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 249.89 Million INR | 29.91% |
| 2022 | 186.81 Million INR | 101.26% |
| 2021 | 92.82 Million INR | 44.22% |
| 2020 | 64.36 Million INR | -55.66% |
| 2019 | 145.14 Million INR | -59.54% |
| 2018 | 358.69 Million INR | 27.56% |
| 2017 | 281.2 Million INR | 0.4% |
| 2016 | 280.09 Million INR | -16.49% |
| 2015 | 335.39 Million INR | 43.28% |
| 2014 | 234.09 Million INR | 41.62% |
| 2013 | 165.3 Million INR | -5.15% |
| 2012 | 174.26 Million INR | -20.97% |
| 2011 | 220.49 Million INR | -0.43% |
| 2010 | 221.44 Million INR | 42.85% |
| 2009 | 155.02 Million INR | 15.91% |
| 2008 | 133.74 Million INR | -41.94% |
| 2007 | 230.37 Million INR | 266.75% |
| 2006 | 62.81 Million INR | 17.89% |
| 2005 | 53.28 Million INR | 350.93% |
| 2004 | -21.23 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 48.55 Million INR | -46.63% |
| 2024 Q2 | 62.23 Million INR | 28.18% |
| 2023 Q4 | 90.97 Million INR | -49.27% |
| 2023 Q3 | 179.34 Million INR | -19.53% |
| 2023 FY | 242.68 Million INR | 29.91% |
| 2023 Q1 | 68.85 Million INR | -75.15% |
| 2023 Q2 | 222.86 Million INR | 223.7% |
| 2022 Q2 | 117.32 Million INR | 1987.17% |
| 2022 Q4 | 277.09 Million INR | 62.91% |
| 2022 FY | 186.81 Million INR | 101.26% |
| 2022 Q1 | 5.62 Million INR | 102.5% |
| 2022 Q3 | 170.09 Million INR | 44.98% |
| 2021 Q2 | 125.23 Million INR | 129.4% |
| 2021 Q1 | 54.59 Million INR | -53.54% |
| 2021 Q3 | 137.88 Million INR | 10.1% |
| 2021 FY | 92.82 Million INR | 44.22% |
| 2021 Q4 | -224.88 Million INR | -263.1% |
| 2020 Q4 | 117.51 Million INR | 39.17% |
| 2020 Q2 | 56.14 Million INR | 233.06% |
| 2020 FY | 64.36 Million INR | -55.66% |
| 2020 Q1 | -42.19 Million INR | -1884.86% |
| 2020 Q3 | 84.43 Million INR | 50.39% |
| 2019 Q3 | 50.44 Million INR | 4.28% |
| 2019 FY | 145.14 Million INR | -59.54% |
| 2019 Q4 | 2.36 Million INR | -95.31% |
| 2019 Q2 | 48.37 Million INR | -1.45% |
| 2019 Q1 | 49.08 Million INR | -29.63% |
| 2018 Q4 | 69.75 Million INR | -0.08% |
| 2018 FY | 358.69 Million INR | 27.56% |
| 2018 Q3 | 69.81 Million INR | -30.25% |
| 2018 Q2 | 100.09 Million INR | -17.76% |
| 2018 Q1 | 121.7 Million INR | -16.71% |
| 2017 Q3 | 171.31 Million INR | 50.26% |
| 2017 Q4 | 146.12 Million INR | -14.7% |
| 2017 FY | 281.2 Million INR | 0.4% |
| 2017 Q1 | -49.82 Million INR | -163.37% |
| 2017 Q2 | 114 Million INR | 328.81% |
| 2016 Q3 | 62.77 Million INR | -22.49% |
| 2016 Q4 | 78.62 Million INR | 25.25% |
| 2016 Q1 | 100.91 Million INR | 137.12% |
| 2016 Q2 | 80.99 Million INR | -19.75% |
| 2016 FY | 280.09 Million INR | -16.49% |
| 2015 Q2 | 85.63 Million INR | 2.04% |
| 2015 Q4 | 42.56 Million INR | -65.48% |
| 2015 FY | 335.39 Million INR | 43.28% |
| 2015 Q1 | 83.92 Million INR | 322.91% |
| 2015 Q3 | 123.27 Million INR | 43.95% |
| 2014 Q1 | 66.4 Million INR | 12331.44% |
| 2014 FY | 234.09 Million INR | 41.62% |
| 2014 Q4 | 19.84 Million INR | -74.78% |
| 2014 Q3 | 78.67 Million INR | 13.74% |
| 2014 Q2 | 69.16 Million INR | 4.16% |
| 2013 Q4 | 534.19 Thousand INR | -99.14% |
| 2013 FY | 165.3 Million INR | -5.15% |
| 2013 Q3 | 62.05 Million INR | -2.04% |
| 2013 Q2 | 63.34 Million INR | 155.26% |
| 2013 Q1 | 24.81 Million INR | 206.68% |
| 2012 FY | 174.26 Million INR | -20.97% |
| 2012 Q2 | 67.44 Million INR | 2.05% |
| 2012 Q1 | 66.09 Million INR | 194.35% |
| 2012 Q4 | -23.26 Million INR | -144.66% |
| 2012 Q3 | 52.08 Million INR | -22.77% |
| 2011 Q4 | 22.45 Million INR | -66.8% |
| 2011 Q3 | 67.63 Million INR | 0.0% |
| 2011 FY | 220.49 Million INR | -0.43% |
| 2010 FY | 221.44 Million INR | 42.85% |
| 2009 FY | 155.02 Million INR | 15.91% |
| 2008 FY | 133.74 Million INR | -41.94% |
| 2007 FY | 230.37 Million INR | 266.75% |
| 2006 FY | 62.81 Million INR | 17.89% |
| 2005 FY | 53.28 Million INR | 350.93% |
| 2004 FY | -21.23 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Abbott India Limited | 13.79 Billion INR | 98.188% |
| Cipla Limited | 105.7 Billion INR | 99.764% |
| Gland Pharma Limited | 16.45 Billion INR | 98.481% |
| GlaxoSmithKline Pharmaceuticals Limited | 13.6 Billion INR | 98.163% |
| Kopran Limited | 675.44 Million INR | 63.004% |
| Marksans Pharma Limited | 7.79 Billion INR | 96.793% |
| NGL Fine-Chem Limited | 416.27 Million INR | 39.969% |
| Pfizer Limited | 9.61 Billion INR | 97.4% |
| Sanofi India Limited | 12.19 Billion INR | 97.951% |
| SMS Pharmaceuticals Limited | 1.34 Billion INR | 81.354% |